Horizon Therapeutics PLC (NASDAQ:HZNP)

106.19
BATS BZX Real-Time Price
As of 12:27pm ET
 +0.12 / +0.11%
Today’s Change
66.41
Today|||52-Week Range
111.70
+45.17%
Year-to-Date
Aerie (AERI) Announces Mixed Data From Dry Eye Disease Study
11:19am / Zacks.com - Paid Partner Content
Horizon (HZNP) Begins Phase IV Study on Tepezza for Chronic TED
Sep 08 / Zacks.com - Paid Partner Content
Here's Why You Should Retain QIAGEN (QGEN) Stock For Now
9:38am / Zacks.com - Paid Partner Content
Here's Why Momentum Investors Will Love Horizon Therapeutics (HZNP)
Sep 03 / Zacks.com - Paid Partner Content
3 Reasons Why Horizon Therapeutics (HZNP) Is a Great Growth Stock
Sep 15 / Zacks.com - Paid Partner Content
Why Is Horizon Therapeutics (HZNP) Up 3.7% Since Last Earnings Report?
Sep 03 / Zacks.com - Paid Partner Content
Is Horizon (HZNP) a Great Growth Stock?
Sep 14 / Zacks.com - Paid Partner Content
Techne (TECH) Soars to 52-Week High, Time to Cash Out?
Sep 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close106.07
Today’s open106.11
Day’s range105.59 - 106.81
Volume9,840
Average volume (3 months)1,361,501
Market cap$24.3B
Data as of 12:27pm ET, 09/16/2021

Growth & Valuation

Earnings growth (last year)-38.99%
Earnings growth (this year)+16.52%
Earnings growth (next 5 years)+18.07%
Revenue growth (last year)+69.26%
P/E ratio43.3
Price/Sales7.16
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+0.14+0.10%
ALNYAlnylam Pharmaceutic...+0.99+0.53%
SGENSeagen Inc-1.29-0.85%
VTRSViatris Inc-0.07-0.51%
Data as of 12:30pm ET, 09/16/2021

Financials

Next reporting dateNovember 8, 2021
EPS forecast (this quarter)$1.54
Annual revenue (last year)$2.2B
Annual profit (last year)$389.8M
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts